# FEBUXOSTAT

NDC: 0527-2244
Generic name: febuxostat
Labeler / Manufacturer: Lannett Company, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200602

FDA application: ANDA213069

## Active ingredients

- FEBUXOSTAT: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0527-2244"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0527-2244
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73b07a94-c044-42dc-abe4-7d7c860c9638